Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease

Plain-language summary

This study examines the effect of transcranial magnetic stimulation (TMS) on thinking skills and brain changes in Parkinson's disease, comparing real stimulation with sham stimulation. It was designed for people with idiopathic Parkinson's disease and mild cognitive changes. The study was conducted as a trial without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

University of Calgary

Intervention

TMS, Sham-TMS

Start date

10/24/2016

Estimated completion

2/14/2020

Countries

Canada

Related genes

Locations

• Calgary, Canada

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Diagnosis of idiopathic Parkinson's disease any stage
* Mild Cognitive Behaviour confirmed through neuropsychological assessment
* MRI Compatibility

Exclusion Criteria:

* Alcohol-dependency
* Severe psychiatric disorder, neurological disorder, epilepsy or stroke
* General anaesthesia in the past six months
* History of cerebrovascular disorders
* Colour-blindness